Author

Cole Werbrich

Cincinnati Children's Hospital Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

Ashok Daniel PrabakaraniD· 1 shared Chiara VillaiD· 1 shared F. E. A. Soussi· 1 shared Hannah LatimeriD· 1 shared Hima Bindu DurumutlaiD· 1 shared Hyun-Jy Chung· 1 shared Kevin McFarland· 1 shared Kevin Piczer· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Ashok Daniel PrabakaranORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel pro-metabolic targets of the glucocorticoid receptor in muscle.

Ashok Daniel Prabakaran, Hyun-Jy Chung, Kevin McFarland, Thirupugal Govindarajan, F. E. A. Soussi, Hima Bindu Durumutla, Chiara Villa, Kevin Piczer, Hannah Latimer, Cole Werbrich, Olukunle Akinborewa, Robert Horning, Mattia Quattrocelli

This study identifies Foxc1 and Arid5a as novel pro-metabolic targets of the glucocorticoid receptor in muscle, using a human SNP rs6190 in mice and human datasets.

Science Advances · Jul 9, 2025Peer-reviewedPhysiology